Brazil authorizes medical cannabis cultivation for first time

Regulatory milestone opens domestic production pathway as patient base nears 900,000.

FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0

Brazil has cleared medical cannabis cultivation for the first time, according to Courthouse News, marking a structural shift in how the country will supply an expanding patient population. As of May 2026, Brazil's medical cannabis patient count had reached 873,000, suggesting substantial domestic demand. The authorization follows months of regulatory groundwork: Anvisa approved cultivation regulations in August 2026, and Brazil's agricultural research agency received cannabis research approval in November 2025.

The move toward domestic production addresses both supply and governance challenges. Earlier regulatory guidance issued in February 2026 established production rules, while recent market coverage indicates new investment interest in the Brazilian cannabis sector. However, related reporting also documents ongoing legal disputes—including a court probe into medical marijuana dealings—suggesting the regulatory framework remains contested even as official authorization proceeds.

Watch whether licensed cultivators begin operations within the next 6–12 months and how domestic supply affects pricing and patient access relative to the current import-dependent model.